NEW ZEALAND: Fight against Botrytis eyes February listing
Botry-Zen, the company that owns the rights to a biological control preventing botrytis in grapevines, will attain a listing on the New Zealand stock exchange in February, it said.
The company has already had to return around NZ$115m in over-subscriptions for the NZ$5m share issue. Botry-Zen's 166m shares were issued at 10c each but have been trading in the mid-20c range, until rising to their current level of 40c two weeks ago.
In a report in New Zealand's National Business Review, Botry-Zen's Howard Paterson said he had been pleased with the speed in which the company had obtained provisional registration with the Ministry of Agriculture and Fisheries, to proceed with commercial production of its product.
Paterson also confirmed that the company was in talks with a US viticulture corporation, which is keen to distribute the product. "We're in talks with this substantial player over there," he told the review, "and they're very impressed with Botry-Zen."
Continuing our 2005 harvest report series, we turn our attention to the wine regions of northern France. Giles Fallowfield reviews this year's crop in Champagne, while Lyn Parry takes a look at the 20...
Beginning just-drinks' annual round-up of harvest reports from European and North American wine regions, Chris Losh reports on this year's vintage in Spain and Portugal....
- The End of the Road for International Beer Brands?
- Allegro: The shape of things to come at Pernod?
- Comment - Another One Bites Bacardi's Dust
- Pernod Ricard's FY Performance by Region, Brand
- US craft vodka puts squeeze on Pernod's Absolut
- Pernod bemoans tough FY as sales, profits drop
- Bacardi announces CFO switch
- ASA bans Jägermeister TV ad
- Pernod Ricard set for CMO switch
- Scotch whisky leaders sign pro-UK letter